Amalgamated Bank’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $8K | Hold |
|
|||||
|
2024
Q3 | $14K | Hold |
|
|||||
|
2024
Q2 | $7K | Hold |
|
|||||
|
2024
Q1 | $14K | Sell |
|
|||||
|
2023
Q4 | $103K | Sell |
|
|||||
|
2023
Q3 | $144K | Hold |
|
|||||
|
2023
Q2 | $318K | Buy |
|
|||||
|
2023
Q1 | $368K | Sell |
|
|||||
|
2022
Q4 | $246K | Buy |
|
|||||
|
2022
Q3 | $313K | Buy |
|
|||||
|
2022
Q2 | $153K | Sell |
|
|||||
|
2022
Q1 | $223K | Sell |
|
|||||
|
2021
Q4 | $202K | Sell |
|
|||||
|
2021
Q3 | $349K | Sell |
|
|||||
|
2021
Q2 | $393K | Buy |
|
|||||
|
2021
Q1 | $227K | Sell |
|
|||||
|
2020
Q4 | $250K | Buy |
|
|||||
|
2020
Q3 | $221K | Buy |
|